Vitamin D and cancer: deciphering the truth

Area of Science:

• Endocrinology and Nutritional Science
• Oncology and Cancer Research

Background:

• Vitamin D, a hormone-like micronutrient, regulates calcium metabolism and diverse biological processes including cell proliferation, apoptosis, angiogenesis, and inflammation.
• These multifaceted roles position vitamin D as a potential therapeutic agent in cancer treatment.
• Preclinical studies indicate vitamin D's promise, both as a monotherapy and in combination regimens.

Purpose of the Study:

• To provide a comprehensive and balanced review of the current scientific evidence on vitamin D's role in cancer.
• To critically interpret existing data from preclinical studies, epidemiological findings, and clinical trials.
• To outline future research directions for defining vitamin D's therapeutic application in cancer management.

Main Methods:

• Systematic review and critical analysis of existing literature.
• Synthesis of data from preclinical investigations, epidemiological studies, and randomized controlled trials.
• Interpretation of conflicting results to identify trends and knowledge gaps.

Main Results:

• Preclinical evidence strongly supports vitamin D's potential as an anticancer agent.
• Epidemiological data suggest an association between vitamin D levels and cancer risk.
• Clinical trial outcomes are inconsistent, highlighting the complexity of vitamin D's role in cancer therapy.

Conclusions:

• The therapeutic potential of vitamin D in cancer warrants further investigation.
• Reconciling conflicting clinical trial data is crucial for establishing evidence-based guidelines.
• Future research should focus on elucidating vitamin D's precise role in cancer prevention and treatment.